Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Ibnsina Pharma's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Ibnsina Pharma's Dividend Payout Ratio or its related term are showing as below:
CAI:ISPH'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.27 Max: 1.09
Current: 0.19
During the past 10 years, the highest Dividend Payout Ratio of Ibnsina Pharma was 1.09. The lowest was 0.19. And the median was 0.27.
CAI:ISPH's Dividend Payout Ratio is ranked better than 80.65% of 62
companies
in the Medical Distribution industry
Industry Median: 0.43
vs CAI:ISPH: 0.19
During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Ibnsina Pharma was 30.50% per year. The lowest was 17.00% per year. And the median was 23.75% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Ibnsina Pharma (CAI:ISPH) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Ibnsina Pharma Dividend Payout Ratio Related Terms
Ibnsina Pharma Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Ibnsina Pharma's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI:ISPH vs MCK, CAH, COR: Dividend Payout Ratio Comparison
For the Medical Distribution subindustry, Ibnsina Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibnsina Pharma Dividend Payout Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ibnsina Pharma's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Ibnsina Pharma's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Ibnsina Pharma's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibnsina Pharma (CAI:ISPH) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Ibnsina Pharma and its competitors. Over the past decade, Ibnsina Pharma's Dividend Payout Ratio has ranged from 0.19 to 1.09. According to the industry distribution chart, Ibnsina Pharma ranks #12 out of 62 companies in the Medical Distribution industry, placing it in the top 19.4%.
Is Ibnsina Pharma's Dividend Payout Ratio too high?
Ibnsina Pharma's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 1.09. Based on the distribution chart, Ibnsina Pharma ranks #12 out of 62 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Ibnsina Pharma has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibnsina Pharma's Dividend Payout Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Ibnsina Pharma ranks #12 out of 62 companies for Dividend Payout Ratio. This places Ibnsina Pharma in the top 19% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.43. Historically, Ibnsina Pharma's own Dividend Payout Ratio has ranged from 0.19 to 1.09 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.43, based on 62 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Ibnsina Pharma and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibnsina Pharma's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibnsina Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ibnsina Pharma (CAI:ISPH) is currently considered Fairly Valued. The stock's GF Value™ is E£10.53, compared to a current price of E£11.38 — trading 8.1% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Ibnsina Pharma's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Ibnsina Pharma (CAI:ISPH), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibnsina Pharma (CAI:ISPH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibnsina Pharma stock appears to be overvalued.
The current stock price of E£11.38 is trading 8.1% above its estimated GF Value™ of E£10.53.
GuruFocus considers Ibnsina Pharma to be Fairly Valued.
Key valuation signals for CAI:ISPH:
Dividend Payout Ratio: 0.00
GF Value™: E£10.53 vs. price of E£11.38 (8.1% above fair value)
No single metric tells the full story. See the CAI:ISPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibnsina Pharma is an Egypt-based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical, and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, packaging, market research, and analysis.
85GF Score
Get the complete analysis for CAI:ISPH
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:ISPH has been successfully added to your 
